FDA Sentinel Initiative: How Big Data Detects Drug Safety Issues
17 Apr 2026Explore how the FDA Sentinel Initiative uses big data and a distributed network to move from passive reporting to active, real-time drug safety monitoring.
Category: Public Policy
Medicare Part D Economics: How Generic Drugs Lower Your Costs
15 Apr 2026Explore the economics of Medicare Part D and discover how tiered formularies and generic drugs significantly reduce out-of-pocket prescription costs for seniors.
Presumed Consent: When Pharmacists Can Substitute Generic Drugs
11 Apr 2026Learn about presumed consent laws in pharmacy substitution, how pharmacists substitute generics without asking, and the impact on patient safety and cost.
Pharmacy Sourcing Requirements: Legitimate Drug Procurement Standards Guide
28 Mar 2026Learn how legitimate drug procurement standards protect patients from counterfeit medicines. We cover sourcing requirements, DSCSA compliance, and supplier vetting.
How FDA Approval Costs for Generics Impact Drug Prices and Patient Access
4 Mar 2026FDA approval costs for generics are not just fees - they shape how fast affordable drugs reach patients. With complex formulations stuck in review limbo, delays cost billions and hurt patients directly.
Regulatory Capture: How Industry Influence Undermines Government Agencies
5 Feb 2026Regulatory capture happens when government agencies prioritize industry interests over public welfare. Learn how this affects your wallet, safety, and democracy, with real examples and solutions.